title: Early direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons.
abstract: The neurochemical profile was examined at postnatal day 3-4 in mutant mice generated by in vivo Cre mediated activation of an attenuated diphtheria toxin gene inserted into the D1 dopamine receptor gene locus. An earlier study of this model had shown that D1 dopamine receptor, substance P and dynorphin were not expressed in the striatum. Quantitative in situ hybridization analysis showed an increase in D2 dopamine receptor and enkephalin messenger RNA expression. The nigrostriatal pathway in the mutant pups was intact with a normal number of dopaminergic neurons in the substantia nigra and the ventral tegmental area in addition to a normal pattern of striatal dopamine transporter and tyrosine hydroxylase immunoreactivity. Quantitative analysis of striatal dopamine transporter density using [3H]mazindol showed a reduction of 26% suggesting a degree of transneuronal down-regulation. There was also a 49% reduction of striatal GABA receptor binding and a 36% reduction of striatal muscarinic receptor binding in mutant pups. The number of healthy striatal neuropeptide Y-containing interneurons was also substantially down-regulated in the mutant striatum. In contrast, there was an increase in the number of striatal cholinergic interneurons. Down-regulated cortical GABA receptor and muscarinic receptor binding was also observed in addition to subtle morphological changes in the neuropeptide Y-expressing population of cortical neurons. The changes reflect the early cascade of events which follows the ablation of D1 dopamine receptor-positive cells. Although extensive changes in a number of striatal and cortical neurons were demonstrated, only subtle transneuronal effects were seen in the nigrostriatal pathway.
authors.affiliation: Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria, Australia.
authors.forename: P
authors.initials: P
authors.lastname: Padungchaichot
authors.forename: J Y
authors.initials: JY
authors.lastname: Wong
authors.forename: A L
authors.initials: AL
authors.lastname: Natoli
authors.forename: J S
authors.initials: JS
authors.lastname: Massalas
authors.forename: D I
authors.initials: DI
authors.lastname: Finkelstein
authors.forename: A L
authors.initials: AL
authors.lastname: Lawrence
authors.forename: J
authors.initials: J
authors.lastname: Drago
mesh_terms: D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism; D001345:Autoradiography; D002352:Carrier Proteins / Q000378:metabolism; D004167:Diphtheria Toxin / Q000235:genetics*; D015870:Gene Expression; D018390:Gene Targeting; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D026901:Membrane Transport Proteins; D051379:Mice; D009474:Neurons / Q000378:metabolism / Q000502:physiology*; D012333:RNA, Messenger / Q000378:metabolism; D017447:Receptors, Dopamine D1 / Q000235:genetics / Q000378:metabolism*; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D050494:Vesicular Acetylcholine Transport Proteins; D033921:Vesicular Transport Proteins
chemical_list: D002352:Carrier Proteins; D004167:Diphtheria Toxin; D026901:Membrane Transport Proteins; D012333:RNA, Messenger; D017447:Receptors, Dopamine D1; C493460:Slc18a3 protein, mouse; D050494:Vesicular Acetylcholine Transport Proteins; D033921:Vesicular Transport Proteins; D014446:Tyrosine 3-Monooxygenase